🔎 Trials Near Me

Home › Neurologic Diseases › Texas › Houston

Neurologic Diseases clinical trials in Houston, TX

6 studies for Neurologic Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

RecruitingPhase 2/3
  • Houston, Texas, Houston
Ages 18 to 70 · All sexes · Updated Oct 2, 2026 · NCT07598708

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

RecruitingPhase 2
  • Houston Methodist Hospital, Houston
  • The University of Texas Health Science Center at Houston, Houston
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

Product Surveillance Registry

RecruitingObservational study
  • Houston, Houston
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Rett Syndrome Registry

RecruitingObservational study
  • Texas Children's Hospital, Houston
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349

Open-label Extension Study in Participants With Early Alzheimer's Disease

RecruitingPhase 2
  • GSK Investigational Site, Houston
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709

About Neurologic Diseases

Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.

More about Neurologic Diseases on MedlinePlus

Neurologic Diseases trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.